Get a Quote

Anagrelide Hydrochloride API | CAS 58579-51-4
CAS NO.: 58579-51-4
Chemical Formula: C10H7Cl2N3O.HCl
Molecular Weight: 292.5500
DMF&GMP status: Please contact us for details
Description:
Anagrelide lowers platelets (blood-clotting cells) in the body, which helps prevent blood clots from forming.

Anagrelide is used to treat a blood cell disorder called thrombocythemia (also called thrombocytosis), which occurs when your body produces too many platelet cells.
Approvals
Active Ingredient Dosage Form; Route Strength Proprietary Name Applicant
ANAGRELIDE HYDROCHLORIDECAPSULE; ORALEQ 0.5MG BASEAGRYLINSHIRE LLC
ANAGRELIDE HYDROCHLORIDE CAPSULE; ORAL EQ 0.5MG BASE ANAGRELIDE HYDROCHLORIDE BARR
ANAGRELIDE HYDROCHLORIDE CAPSULE; ORAL EQ 1MG BASE ANAGRELIDE HYDROCHLORIDE BARR
ANAGRELIDE HYDROCHLORIDE CAPSULE; ORAL EQ 0.5MG BASE ANAGRELIDE HYDROCHLORIDE IMPAX LABS
ANAGRELIDE HYDROCHLORIDE CAPSULE; ORAL EQ 1MG BASE ANAGRELIDE HYDROCHLORIDE IMPAX LABS
ANAGRELIDE HYDROCHLORIDE CAPSULE; ORAL EQ 0.5MG BASE ANAGRELIDE HYDROCHLORIDE IVAX SUB TEVA PHARMS
ANAGRELIDE HYDROCHLORIDE CAPSULE; ORAL EQ 1MG BASE ANAGRELIDE HYDROCHLORIDE IVAX SUB TEVA PHARMS
ANAGRELIDE HYDROCHLORIDE CAPSULE; ORAL EQ 0.5MG BASE ANAGRELIDE HYDROCHLORIDE MYLAN
ANAGRELIDE HYDROCHLORIDE CAPSULE; ORAL EQ 1MG BASE ANAGRELIDE HYDROCHLORIDE MYLAN
ANAGRELIDE HCL CAPSULE; ORAL EQ 0.5MG BASE ANAGRELIDE HYDROCHLORIDE MYLAN PHARMS INC
CAPSULE; ORAL EQ 1MG BASE ANAGRELIDE H MYLAN PHARMS INC
Patent Data
Patent No. Patent Expiration Drug Substance Claim Drug Product Claim Patent Use Code
Exclusive Data
Exclusivity Code Exclusivity Expiration